Execs On The Move, November 2014
Executive Summary
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
| Table |
|---|
Advertisement
Topics
- Industries
- Medical Device
- BioPharmaceutical
Related Companies
- Sensory Medical Inc.
- Angiotech Pharmaceuticals Inc.
- Sunovion CNS Development Canada ULC
- Nabriva Therapeutics PLC
- Medidata Solutions Inc.
- Rafael Pharmaceuticals Inc.
- ChemoCentryx Inc.
- Quest Diagnostics Inc.
- GI Dynamics Inc.
- Biogen Inc.
- GE Healthcare
- Agendia BV
- ADC Therapeutics SARL
- GE Healthcare
- Eiger BioPharmaceuticals Inc.
- Sierra Oncology Inc.
- Pivotal Therapeutics Inc.
- Thoratec Corp.
- Flex Pharma Inc.
- BBB technologies BV
- NewLink Genetics Corp.
- Epizyme Inc.
- Biodesix Inc.
- Alnylam Pharmaceuticals Inc.
- Guardant Health Inc.
- Avillion LLP
- BBB technologies BV
- Synlogic Inc.
- Noxxon Pharma AG
- CollPlant Ltd.
- New Haven Pharmaceuticals Inc.
- New Haven Pharmaceuticals Inc.
- Myriad Genetics Inc.
- Avalanche Biotechnologies Inc.
- Delphinus Medical Technologies Inc.
- Array BioPharma Inc.
- Epizyme Inc.
- NeoGenomics Inc.
- Synlogic Inc.
- Five Prime Therapeutics Inc.
- bioTheranostics Inc.
- Ignyta Inc.
- OvaScience Inc.
- Amedica Corp.
- Exelixis Inc.
- BBB technologies BV
- Bio-Rad Laboratories Inc.
- Alexion Pharmaceuticals Inc.
- Medtronic Minimally Invasive Therapies
- PDL BioPharma Inc.
- Abcam PLC
- Cardinal Health Inc.
- Voyager Therapeutics Inc.
- Meda AB
- Retrophin Inc.
- Intellipharmaceutics International Inc.
- Cytori Therapeutics Inc.
- Avadel Pharmaceuticals PLC
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IV004154
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
IV004154
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.